Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxotere and Cisplatin in Advanced Adrenocortical Carcinoma
NCT00324012Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2006
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin in adrenocortical carcinoma (ACC), sponsored by Rigshospitalet. Started Apr 2006; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT00324012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324012.